Search

Displaying results 8561 - 8570 of 10000 in total
  1. Drug

    Ocaratuzumab

    go.drugbank.com/drugs/DB17359
    Investigational

    Ocaratuzumab is a humanized monoclonal antibody directed against CD20. It is being investigated for cancers and autoimmune disorders.

    Synonyms: Immunoglobulin G1, anti-(human B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1, Bp35, leukocyte surface antigen Leu-16, membrane-spanning 4-domains subfamily A member 1))
  2. Drug

    LioCyx-M004

    go.drugbank.com/drugs/DB17368
    Investigational

    LioCyx-M004 are autologous T cells transduced with a retroviral vector encoding a hepatitis B virus antigen-specific T cell receptor.

  3. Drug

    Zanolimumab

    go.drugbank.com/drugs/DB17376
    Investigational

    Zanolimumab is a fully human monoclonal antibody directed against CD4.

  4. Drug

    Becotatug vedotin

    go.drugbank.com/drugs/DB17407
    Investigational

    MRG-003 is a recombinant humanized anti-human epidermal growth factor receptor monoclonal antibody conjugated to monomethyl auristatin E.

  5. Drug

    TNG908

    go.drugbank.com/drugs/DB17411
    Investigational

    TNG908 is a small molecule inhibitor of protein arginine methyl transferase 5 (PRMT5).

  6. Drug

    SCH-58500

    go.drugbank.com/drugs/DB17416
    Investigational

    SCH-58500 is a recombinant replication-deficient adenovirus vector carrying the human p53 gene.

  7. Drug

    S-3APG

    go.drugbank.com/drugs/DB17419
    Experimental

    S-3APG (S-3-[3-amino-phthalimido]-glutarimide) is a derivative of thalidomide with dual activity against B-cell neoplasias.[A255168]

  8. Drug

    Allovectin-7

    go.drugbank.com/drugs/DB17439
    Investigational

    Allovectin-7 or allovectin-7(r) is a lipid complex that contains the DNA sequences encoding HLA-B7 and beta-2 microglobulin.

  9. Drug

    Lym-1-I-131

    go.drugbank.com/drugs/DB17445
    Experimental

    Lym-1-I-131 is a monoclonal antibody labeled with iodine-131 (131I) that preferentially targets malignant lymphocytes.

  10. Drug

    MK-0482

    go.drugbank.com/drugs/DB17453
    Investigational

    MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.